Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 186HER2-positive Breast Cancer 18Neoplasm Metastasis 6Inflammatory Breast Neoplasms 5Triple Negative Breast Neoplasms 4Neoplasms 4Prostatic Neoplasms 3Pathologic Complete Response 3Pancreatic Neoplasms 3HER2-positive Early Breast Cancer 3Endometrial Neoplasms 3Breast Neoplasms, Male 3Anatomic Stage I Breast Cancer AJCC v8 3Stomach Neoplasms 2Ovarian Neoplasms 2Multiple Myeloma 2Locally Advanced Breast Cancer 2Hematologic Neoplasms 2HER2-positive Metastatic Breast Cancer 2Gastrointestinal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Ductal, Breast 2Breast Diseases 2Brain Neoplasms 2Anatomic Stage II Breast Cancer AJCC v8 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Thrombocytosis 1

Interventions

pembrolizumab 6Paclitaxel 3Docetaxel 3Cyclophosphamide 3eribulin 2Oncolytic Virotherapy 2tislelizumab 1tirbanibulin 1spartalizumab 1poly ICLC 1pertuzumab 1pemigatinib 1pegfilgrastim 1obinutuzumab 1ixabepilone 1fludarabine phosphate 1fludarabine 1etirinotecan pegol 1efineptakin alfa 1durvalumab 1atezolizumab 1aldesleukin 1advexin 1Yoga 1Vinorelbine 1Tomography, X-Ray Computed 1Surveys and Questionnaires 1Ritonavir 1Radiotherapy 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × pertuzumab × Breast × Clear all
NCT05150691 2026-01-28

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

DualityBio Inc.

Phase 1/2 Recruiting
796 enrolled
BreastGastrointestinalGynecologicThoracic

Bile Duct Neoplasms, Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡